Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Corcept Therapeutics Incorporated (CORT) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$194.43M |
|
$34.61M |
|
$3.43M |
|
$191.00M |
|
$167.75M |
|
$26.68M |
|
$5.02M |
|
$31.69M |
|
$31.69M |
|
$35.15M |
|
$35.15M |
|
$35.15M |
|
$35.15M |
|
$26.68M |
|
$27.14M |
|
104.11M |
|
120.48M |
|
$0.33 |
|
$0.29 |
|
| Balance Sheet Financials | |
$443.11M |
|
$2.35M |
|
$358.61M |
|
$801.72M |
|
$144.66M |
|
-- |
|
$21.27M |
|
$165.93M |
|
$635.79M |
|
$635.79M |
|
$635.79M |
|
105.29M |
|
| Cash Flow Statement Financials | |
$49.07M |
|
$66.96M |
|
$-142.74M |
|
$127.67M |
|
$102.75M |
|
$-24.92M |
|
$40.85M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.06 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
98.23% |
|
13.72% |
|
13.72% |
|
-- |
|
16.30% |
|
17.80% |
|
$48.91M |
|
-- |
|
-- |
|
-- |
|
0.24 |
|
0.28 |
|
3.01 |
|
29.89 |
|
5.53% |
|
5.53% |
|
4.38% |
|
5.53% |
|
$6.04 |
|
$0.41 |
|
$0.41 |
|